High Rate of Transplantation Prior to Review of Status Exception Requests among Adult Heart Transplant Candidates
Ahn, D. J.; Nakayama, T.; Attia, A. M.; White, M.; Eap, D.; Narang, N.; Khush, K. K.; Parker, W. F.; Sasaki, K.
Show abstract
BackgroundIn the United States heart allocation system, when transplant centers submit applications for status exceptions to increase waitlist priority, patients obtain the requested status upgrades immediately while their applications are sent to the regional review boards (RRBs) and reviewed retrospectively. How much time elapses between obtaining a status upgrade through exception and application receipt by the RRBs and how often transplants occur during this period is unknown. MethodsUsing the Scientific Registry of Transplant Recipients (SRTR), we identified all adult heart transplant candidates listed between October 18, 2018 and December 31, 2023 with submitted applications for status exceptions. We assessed 1) the amount of time elapsed between submission of exception applications and their receipt by the RRBs and 2) the rate of heart transplantation during this "travel" time, stratified by whether the applications were eventually approved or denied. Additionally, using complete match run data, we estimated how many listed patients were skipped by candidates who received transplants with exceptions that were ultimately denied. Results135 transplant centers submitted status exception requests on behalf of 8,269 adult candidates during the study period, of whom 608 (7.4%) received a denial at least once. The median time from obtaining higher priority statuses immediately via exceptions to application receipt by the RRBs was 3 days. 2,087 out of 8,269 (25.2%) patients received transplants before the RRBs even received their applications, with 115 (18.9%) among 608 with eventual denials and 1,972 (25.7%) among 7,661 with approvals. The cumulative incidence of heart transplantation before application receipt for eventual denials was 19.1% (95% CI [16.0%, 22.3%]) and that for approvals was 26.2% (95% CI [25.2%, 27.1%]) (p < 0.001) at 2 weeks. Based on match run data, the 115 patients who received transplants with denied exceptions bypassed more than seven thousand potential transplant recipients. ConclusionsMore than 25% of patients with status exception requests receive heart transplants before their applications are even received by their respective RRBs, let alone reviewed. This raises significant concerns about the efficacy and fairness of retrospective review of exception requests for the allocation of valuable donor hearts.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20 Center Retrospective Cohort Study 95%
- Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis 92%
- Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator 92%
Similar papers in this journal
Similar papers in this journal
- A Pilot Randomized Controlled Trial of de novo Belatacept-Based Immunosuppression in Lung Transplantation 93%
- Balancing Equity and HLA Matching in Deceased-Donor Kidney Allocation with Eplet Mismatch 92%
- Predicting Post-Liver Transplant Outcomes in Patients with Acute-on-Chronic Liver Failure using Expert-Augmented Machine Learning 91%
Similar papers in this journal
- Trends in Mechanical Circulatory Support utilization, Left Ventricular Assist Device implantation and Transplant during Cardiogenic Shock Hospitalizations, after the New Heart Allocation Policy 95%
- Inpatient Outcomes Of Mechanical Circulatory Support Devices and Bridging to Transplantation in Hypertrophic Cardiomyopathy 91%
- Early left ventricular systolic function is a more sensitive predictor of adverse events after heart transplant 90%
Similar papers in this journal
- Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes 86%
- Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization and death: a target trial emulation in the omicron (B.1.1.529) variant era 86%
- Years of Life Lost in the United States During the COVID-19 Pandemic, March 2020 to October 2021 85%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.